Post Marketing Surveillance Study of Biphasic Insulin Aspart 30

NovoMix® 30 FlexPen, Post Marketing Surveillance Study

This study is conducted in Asia. The aim of this study is to review the safety and efficacy of biphasic insulin aspart 30 in post-marketing use.

Inclusion Criteria:

• Subjects with diabetes who did not have indications that are contraindicated in the product insert